Insight and skilled decision-making are crucial in prostate cancer (PCa) diagnosis and treatment. The 3rd EAU Update on Prostate Cancer, to be held from 11-12 October in Prague, the Czech Republic, addresses this challenge with an expert-led meeting that is both comprehensive and compact.
Unique with its fully interactive format, prostate cancer experts from across Europe will challenge participants with a critical assessment of standard and prospective PCa therapies. In collaboration with the European School of Urology (ESU), the two day programme will examine key topics in optimal PCa management.
From insightful overviews to point-by-point assessment of treatment strategies, expert lecturers will take participants through a range of issues on current guidelines, clinical dilemmas, and medical management. Stock knowledge will be tested against the impact of new drug research and evolving use of imaging technologies. With incisive, to-the-point commentary, the faculty will tackle systemic treatments, metastatic disease, drug sequencing and complications management.
Pre- and post-meeting testing will be required for a thorough assessment of the participant’s gain in knowledge and skills improvement. While emphasising evidence-based medicine, interactive breakout sessions will explore difficulties in diagnosis, use of imaging tools, and effective follow-up strategies. Case discussions and topic-focused sessions led by a rotating faculty will aim for in-depth inquiry into contentious issues such as local salvage therapy, active surveillance and managing recurrent disease.
PCa19, as part of the onco-urology educational series organised by the EAU, is an opportunity in continuing medication education that responds to cancer and healthcare professionals looking for a practical, comprehensive and incisive update.
Join us in Prague!
|Dr. Joan Palou
Chair European School of Urology
|Prof. Manfred Wirth
EAU Treasurer and Executive Member Communications
Share the EAU Update on Prostate Cancer Meeting 2019 with your friends and colleagues: